Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo A Cunha

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
Purinergic Signalling|April 12, 2008
Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockadeRodrigo A Cunha
Journal of Neurochemistry|July 2, 2016
How does adenosine control neuronal dysfunction and neurodegeneration?Rodrigo A Cunha
Plos Biology|April 6, 2019
Signaling by adenosine receptors-Homeostatic or allostatic control?Rodrigo A Cunha
Medicina Clinica|December 20, 2008
[Caffeine, adenosine receptors, memory and Alzheimer disease]Rodrigo A Cunha
Brain : a Journal of Neurology|October 31, 2019
Overactivity of neuronal adenosine A2A receptors accelerates neurodegenerationRodrigo A Cunha
British Journal of Pharmacology|June 6, 2003
Heteroexchange of purines in the hippocampus: mixing-up or messing-up ATP and adenosineRodrigo A Cunha
Neurochemistry International|August 1, 2007
Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticityRodrigo A Cunha
Nutrients|October 17, 2020
The Coffee-Acrylamide Apparent Paradox: An Example of Why the Health Impact of a Specific Compound in a Complex Mixture Should Not Be Evaluated in IsolationAstrid Nehlig, Rodrigo A Cunha
Journal of Neurochemistry|May 8, 2019
What is the extracellular calcium concentration within brain synapses?: An Editorial for 'Ionized calcium in human cerebrospinal fluid and its influence on intrinsic and synaptic excitability of hippocampal pyramidal neurons in the rat' on page 452João Pedro Lopes, Rodrigo A Cunha
Purinergic Signalling|April 3, 2020
The belated US FDA approval of the adenosine A<sub>2A</sub> receptor antagonist istradefylline for treatment of Parkinson's diseaseJiang-Fan Chen, Rodrigo A Cunha
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
Purinergic Signalling|April 12, 2008
Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockadeRodrigo A Cunha
Journal of Neurochemistry|July 2, 2016
How does adenosine control neuronal dysfunction and neurodegeneration?Rodrigo A Cunha
Plos Biology|April 6, 2019
Signaling by adenosine receptors-Homeostatic or allostatic control?Rodrigo A Cunha
Medicina Clinica|December 20, 2008
[Caffeine, adenosine receptors, memory and Alzheimer disease]Rodrigo A Cunha
Brain : a Journal of Neurology|October 31, 2019
Overactivity of neuronal adenosine A2A receptors accelerates neurodegenerationRodrigo A Cunha
British Journal of Pharmacology|June 6, 2003
Heteroexchange of purines in the hippocampus: mixing-up or messing-up ATP and adenosineRodrigo A Cunha
Neurochemistry International|August 1, 2007
Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticityRodrigo A Cunha
Nutrients|October 17, 2020
The Coffee-Acrylamide Apparent Paradox: An Example of Why the Health Impact of a Specific Compound in a Complex Mixture Should Not Be Evaluated in IsolationAstrid Nehlig, Rodrigo A Cunha
Journal of Neurochemistry|May 8, 2019
What is the extracellular calcium concentration within brain synapses?: An Editorial for 'Ionized calcium in human cerebrospinal fluid and its influence on intrinsic and synaptic excitability of hippocampal pyramidal neurons in the rat' on page 452João Pedro Lopes, Rodrigo A Cunha
Purinergic Signalling|April 3, 2020
The belated US FDA approval of the adenosine A<sub>2A</sub> receptor antagonist istradefylline for treatment of Parkinson's diseaseJiang-Fan Chen, Rodrigo A Cunha
Pageof 26